Biogen, Inc. (BIIB)
176.02
-4.52
(-2.50%)
USD |
NASDAQ |
Apr 16, 16:00
175.99
-0.03
(-0.02%)
After-Hours: 20:00
Biogen Market Cap : 25.83B for April 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 188.34B |
| Gilead Sciences, Inc. | 172.00B |
| Johnson & Johnson | 564.92B |
| Apellis Pharmaceuticals, Inc. | 5.224B |
| Moderna, Inc. | 21.69B |
Market Cap Related Metrics
| PE Ratio | 19.99 |
| PS Ratio | 2.710 |
| Price to Book Value | 1.415 |
| Price to Free Cash Flow | 13.12 |
| Price | 176.02 |
| Earnings Yield | 5.00% |
| Operating PE Ratio | 10.67 |
| Normalized PE Ratio | 15.10 |